BiotechTube
Home/Lateral Pharma/David Williamson
DW

David Williamson

CFO & Company Secretary

Lateral Pharma

Therapeutic Areas

OncologyImmunologyNeurologyPainInfectious Disease

Lateral Pharma Pipeline

DrugIndicationPhase
LAT9997Neuropathic PainPhase 2 (next-gen)
LAT8881Lumbar Radicular Pain (Sciatica)Phase 1b
SCP PlatformAlzheimer's Disease / NeurodegenerationPreclinical

Leadership Team at Lateral Pharma

DK
David Kenley
CEO & Managing Director
AG
Andy Gearing
Chief Scientific Officer
SM
Stuart Mudge
Chief Operating Officer
View full Lateral Pharma profile